ECHA nIeuws 14-11-24
14-11-2024
Klik op de artikels om op de hoogte te blijven van de laatste ontwikkelingen bij ECHA over volgende onderwerpen:
Info:
ECHA to investigate new test method potentially replacing toxicity testing with fish
IT Tools:
New IUCLID service release published
We will carry out maintenance work on our IT tools in the coming weekend.
The break will start on Friday 15 November 2024 at 18:00 (Helsinki time) and affect the following tools:
- eChemPortal
- HelpEx
All tools are available again on Monday 18 October 2024 at 12:00 (Helsinki time).
Reach:
- Consultations launched for applications for
authorisation -
New substance evaluation conclusions published
- Bis(isopropyl)naphthalene (EC 254-052-6, CAS 38640-62-9), evaluated by Sweden.
- Imidazolium compounds, 2-C17-unsatd.-alkyl-1-(2-C18-unsatd. amidoethyl)-4,5-dihydro-N-methyl, Me sulfates (EC 931-745-8), evaluated by Sweden.
-
Assessment of regulatory needs report published
Report for the following substance group is now available on our website:
CLP:
Updated guidance on new CLP criteria
We have updated our guidance on applying the classification, labelling and packaging (CLP) regulation.
It covers advice on the new hazard criteria for
- endocrine disruptors (ED) for human health or the environment;
- persistent, bioaccumulative and toxic (PBT); very persistent and very bioaccumulative (vPvB) substances; and
- persistent, mobile and toxic (PMT); very persistent and very mobile (vPvM) substances.
Biocides:
New quality rules introduced in IUCLID update
Occupational exposure limits:
RAC opinion on the scientific evaluation of
occupational exposure limits
We have published the opinion of our Committee for Risk Assessment (RAC) for:
European Commission:
Biocides decision on Union authorisation
The Commission has granted a Union authorisation for:
- the biocidal product family 'Teat disinfectants L-(+)-lactic acid based biocidal product family of Novadan'.
EU Observatory for Nanomaterials (EUON):
New study on nanomaterial applications for agriculture
We have published a new study